KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Inventory Average (2016 - 2025)

AbbVie (ABBV) has disclosed Inventory Average for 13 consecutive years, with $4.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average rose 14.58% to $4.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.9 billion, a 14.58% increase, with the full-year FY2025 number at $4.6 billion, up 10.29% from a year prior.
  • Inventory Average was $4.9 billion for Q4 2025 at AbbVie, roughly flat from $4.9 billion in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $4.9 billion in Q3 2025 to a low of $3.1 billion in Q4 2021.
  • A 5-year average of $3.9 billion and a median of $4.0 billion in 2023 define the central range for Inventory Average.
  • Biggest YoY gain for Inventory Average was 79.98% in 2021; the steepest drop was 13.98% in 2021.
  • AbbVie's Inventory Average stood at $3.1 billion in 2021, then grew by 8.5% to $3.4 billion in 2022, then grew by 19.69% to $4.0 billion in 2023, then grew by 6.82% to $4.3 billion in 2024, then rose by 14.58% to $4.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Inventory Average are $4.9 billion (Q4 2025), $4.9 billion (Q3 2025), and $4.7 billion (Q2 2025).